CEPHALON INC|4Oct 17, 12:34 PM ET

CEPHALON INC 4

4 · CEPHALON INC · Filed Oct 17, 2011

Insider Transaction Report

Form 4

Period: 2011-10-14

CEPHALON INCCEPH

EGAN WILLIAM P

Director

Transactions

Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−10,000→ 0 total
Exercise: $58.67From: 2006-05-15Exp: 2012-05-15→ Common Stock (10,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−10,000→ 0 total
Exercise: $44.09From: 2009-05-18Exp: 2015-05-18→ Common Stock (10,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−10,000→ 0 total
Exercise: $79.99From: 2011-05-17Exp: 2017-05-17→ Common Stock (10,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−10,000→ 0 total
Exercise: $66.55From: 2013-05-12Exp: 2019-05-12→ Common Stock (10,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−10,000→ 0 total
Exercise: $60.08From: 2010-05-17Exp: 2016-05-17→ Common Stock (10,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−15,000→ 0 total
Exercise: $79.85From: 2015-05-10Exp: 2021-05-10→ Common Stock (15,000 underlying)
Disposition to Issuer
Common Stock
2011-10-14−21,661→ 0 total(indirect: By Trust)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−15,000→ 0 total
Exercise: $59.18From: 2014-05-20Exp: 2020-05-20→ Common Stock (15,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−10,000→ 0 total
Exercise: $45.23From: 2007-05-29Exp: 2013-05-29→ Common Stock (10,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−10,000→ 0 total
Exercise: $54.50From: 2008-05-13Exp: 2014-05-13→ Common Stock (10,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option
2011-10-14−10,000→ 0 total
Exercise: $67.66From: 2012-05-22Exp: 2018-05-22→ Common Stock (10,000 underlying)

Footnotes (3)

[F1]Common Stock was converted pursuant to the Agreement and Plan of Merger, dated as of May 1, 2011, among Teva Pharmaceutical Industries Ltd., Copper Acquisition Corp. and Cephalon, Inc. (the "Merger Agreement") into the right to receive the Merger Consideration (as defined in the Merger Agreement) of $81.50 per share in cash.
[F2]Options were canceled at the Effective Time of the Merger pursuant to the terms of the Merger Agreement in exchange for a cash payment for each share subject to the option equal to the difference between the Merger Consideration of $81.50 per share and the exercise price of the option.
[F3]Reflects four-year anniversary from date of grant. Options vest 25% on each anniversary of grant and expire ten years from date of grant.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT